Answer
It can inhibit CYP3A4 and raise ranolazine exposure, increasing the likelihood of adverse effects.
Sources for this answer
- Ranolazine Aspire 375mg Prolonged-Release Tabletsemc · SmPC Current selected SmPC · Version 1
loading page…
Explore the tools and reference material available on iatroX.
Explore askiatroX